Low-Dose Interleukin-2 for Refractory Autoimmune Hepatitis. (2018)
Attributed to:
USE OF LOW-DOSE IL-2 TO EXPAND ENDOGENOUS REGULATORY T CELLS AND ACHIEVE TRANSPLANTATION TOLERANCE
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/hep.30059
PubMed Identifier: 29698571
Publication URI: http://europepmc.org/abstract/MED/29698571
Type: Journal Article/Review
Volume: 68
Parent Publication: Hepatology (Baltimore, Md.)
Issue: 4
ISSN: 0270-9139